个性化文献订阅>期刊> Blood
 

A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis

  作者 Tremmel, M; Matzke, A; Albrecht, I; Laib, AM; Olaku, V; Ballmer-Hofer, K; Christofori, G; Heroult, M; Augustin, HG; Ponta, H; Orian-Rousseau, V  
  选自 期刊  Blood;  卷期  2009年114-25;  页码  5236-5244  
  关联知识点  
 

[摘要]A specific splice variant of the CD44 cell-surface protein family, CD44v6, has been shown to act as a coreceptor for the receptor tyrosine kinase c-Met on epithelial cells. Here we show that also on endothelial cells (ECs), the activity of c-Met is dependent on CD44v6. Furthermore, another receptor tyrosine kinase, VEGFR-2, is also regulated by CD44v6. The CD44v6 ectodomain and a small peptide mimicking a specific extracellular motif of CD44v6 or a CD44v6-specific antibody prevent CD44v6-mediated receptor activation. This indicates that the extracellular part of CD44v6 is required for interaction with c-Met or VEGFR-2. In the cytoplasm, signaling by activated c-Met and VEGFR-2 requires association of the CD44 carboxy-terminus with ezrin that couples CD44v6 to the cytoskeleton. CD44v6 controls EC migration, sprouting, and tubule formation induced by hepatocyte growth factor (HGF) or VEGF-A. In vivo the development of blood vessels from grafted EC spheroids and angiogenesis in tumors is impaired by CD44v6 blocking reagents, suggesting that the coreceptor function of CD44v6 for c-Met and VEGFR-2 is a promising target to block angiogenesis in pathologic conditions. (Blood. 2009; 114: 5236-5244)

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内